ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,905, issued on Aug. 12, was assigned to Kromnigon AB.

"Method for the formation and use of an immunolabeling complex" was invented by Per Fogelstrand (Molndal, Sweden) and Ulf Yrlid (Gothenburg, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally relates to method for forming an immunolabeling complex, the immunolabeling complex comprising a labeled monovalent biotin-binding composition. The invention also related to the use of the antibody-reporter molecule complex for detecting a target in a sample."

The patent was filed on Feb. 8, 2022, under Application No. 17/667,153.

*For further information, including image...